With an $8 million seed investment led by The Engine, Droplet will develop a novel lymph liquid biopsy for earlier, more precise care following surgery.  https://www.businesswire.com/news/home/20230316005040/en/Droplet-Biosciences-Announces-Lymph-Diagnostic-Platform-to-Help-Prevent-Cancer-Recurrence CAMBRIDGE, MA – March 16, 2023 – Droplet Biosciences today announced an $8 million seed investment to establish proof of concept for the company’s technology. While the lymphatic system’s … Continue reading Droplet Biosciences Announces Lymph Diagnostic Platform to Help Prevent Cancer Recurrence